MAFENIDE ACETATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Mafenide Acetate, and what generic alternatives are available?
Mafenide Acetate is a drug marketed by Novast Labs and Par Form and is included in two NDAs.
The generic ingredient in MAFENIDE ACETATE is mafenide acetate. There are four drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mafenide acetate profile page.
Summary for MAFENIDE ACETATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 106 |
Clinical Trials: | 2 |
Patent Applications: | 1,043 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for MAFENIDE ACETATE |
DailyMed Link: | MAFENIDE ACETATE at DailyMed |
Recent Clinical Trials for MAFENIDE ACETATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Maricopa Integrated Health System | N/A |
PuriCore, Inc. | N/A |
Valleywise Health | N/A |
Pharmacology for MAFENIDE ACETATE
Drug Class | Methylated Sulfonamide Antibacterial |
Medical Subject Heading (MeSH) Categories for MAFENIDE ACETATE
Anatomical Therapeutic Chemical (ATC) Classes for MAFENIDE ACETATE
US Patents and Regulatory Information for MAFENIDE ACETATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novast Labs | MAFENIDE ACETATE | mafenide acetate | FOR SOLUTION;TOPICAL | 206716-001 | Jul 31, 2017 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Par Form | MAFENIDE ACETATE | mafenide acetate | FOR SOLUTION;TOPICAL | 201511-001 | Feb 12, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |